Wenyi Lu

1.6k total citations
60 papers, 958 citations indexed

About

Wenyi Lu is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Wenyi Lu has authored 60 papers receiving a total of 958 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 15 papers in Molecular Biology and 14 papers in Hematology. Recurrent topics in Wenyi Lu's work include CAR-T cell therapy research (21 papers), Virus-based gene therapy research (12 papers) and Immune Cell Function and Interaction (8 papers). Wenyi Lu is often cited by papers focused on CAR-T cell therapy research (21 papers), Virus-based gene therapy research (12 papers) and Immune Cell Function and Interaction (8 papers). Wenyi Lu collaborates with scholars based in China and Canada. Wenyi Lu's co-authors include Mingfeng Zhao, Xin Jin, Xiaoyuan He, Xia Xiao, Rui Sun, Juanxia Meng, Xiao Chai, Juan Mu, Lin Cheng and Cuicui Lyu and has published in prestigious journals such as Blood, Scientific Reports and Chemosphere.

In The Last Decade

Wenyi Lu

56 papers receiving 946 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenyi Lu China 17 372 307 242 207 175 60 958
Seongseok Yun United States 18 464 1.2× 344 1.1× 306 1.3× 248 1.2× 147 0.8× 79 1.1k
Patrick J. Kerzic United States 14 241 0.6× 342 1.1× 180 0.7× 123 0.6× 148 0.8× 19 775
Imran Ahmad Canada 15 225 0.6× 245 0.8× 323 1.3× 122 0.6× 92 0.5× 92 1.1k
Hisakazu Nishimori Japan 14 168 0.5× 326 1.1× 105 0.4× 161 0.8× 525 3.0× 82 961
Keisuke Maeshima Japan 15 181 0.5× 191 0.6× 272 1.1× 121 0.6× 219 1.3× 33 845
Sergiu Paşca Romania 15 84 0.2× 166 0.5× 216 0.9× 94 0.5× 86 0.5× 68 591
Klara Dalva Türkiye 13 97 0.3× 231 0.8× 106 0.4× 111 0.5× 159 0.9× 73 649
Alexander Gural Israel 18 136 0.4× 313 1.0× 328 1.4× 111 0.5× 53 0.3× 48 885
Е. Н. Паровичникова Russia 11 179 0.5× 301 1.0× 126 0.5× 276 1.3× 107 0.6× 226 688
Michaela Schwarz Germany 18 184 0.5× 452 1.5× 203 0.8× 313 1.5× 34 0.2× 46 1.1k

Countries citing papers authored by Wenyi Lu

Since Specialization
Citations

This map shows the geographic impact of Wenyi Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenyi Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenyi Lu more than expected).

Fields of papers citing papers by Wenyi Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenyi Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenyi Lu. The network helps show where Wenyi Lu may publish in the future.

Co-authorship network of co-authors of Wenyi Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Wenyi Lu. A scholar is included among the top collaborators of Wenyi Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenyi Lu. Wenyi Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Meng, Xiaomei Zhang, Jiaxi Wang, et al.. (2025). Utilization of donor CLL-1 CAR-T cells for the treatment of relapsed of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation. Frontiers in Immunology. 15. 1491341–1491341.
2.
Gao, Xuejin, et al.. (2023). Developing Strategies to Improve the Efficacy of CAR-T Therapy for Acute Myeloid Leukemia. Current Treatment Options in Oncology. 24(11). 1614–1632. 3 indexed citations
3.
4.
Jin, Xin, et al.. (2023). “Off-the-Shelf” Allogeneic CAR Cell Therapy—Neglected HvG Effect. Current Treatment Options in Oncology. 24(5). 409–441. 8 indexed citations
5.
Zhang, Yajie, Wenyi Lu, Ji Li, et al.. (2023). Tri-ponderal mass index as a screening tool for obesity prediction in children aged 6–9 years. Frontiers in Endocrinology. 14. 1277125–1277125.
6.
Zhao, Yifan, Yi Zhang, Wenyi Lu, et al.. (2023). The diagnostic/prognostic roles and biological function of the IFIT family members in acute myeloid leukemia. BMC Medical Genomics. 16(1). 296–296. 4 indexed citations
7.
Lyu, Hairong, et al.. (2023). Epstein‒Barr virus–associated cellular immunotherapy. Cytotherapy. 25(9). 903–912. 10 indexed citations
8.
Jin, Xin, et al.. (2023). Small-Molecule Compounds Boost CAR-T Cell Therapy in Hematological Malignancies. Current Treatment Options in Oncology. 24(3). 184–211. 20 indexed citations
9.
Zhang, Yi, et al.. (2023). Targeted CD7 CAR T-cells for treatment of T-Lymphocyte leukemia and lymphoma and acute myeloid leukemia: recent advances. Frontiers in Immunology. 14. 1170968–1170968. 18 indexed citations
10.
Liu, Shiyu, Fan Li, Li Deng, et al.. (2023). Claudin18.2 bispecific T cell engager armed oncolytic virus enhances antitumor effects against pancreatic cancer. Molecular Therapy — Oncolytics. 30. 275–285. 6 indexed citations
11.
Cheng, Lin, Xin Jin, Wenyi Lu, et al.. (2021). [Effect and Involved Mechanism of RSL3-induced Ferroptosis in Acute Leukemia Cells MOLM13 and Drug-resistant Cell Lines].. 29(4). 1109–1118. 1 indexed citations
12.
Lyu, Hairong, Xiaoyuan He, Hong-Jun Hao, et al.. (2021). Noninvasive tools based on immune biomarkers for the diagnosis of central nervous system graft-vs-host disease: Two case reports and a review of the literature. World Journal of Clinical Cases. 9(6). 1359–1366. 3 indexed citations
13.
Liu, Meijing, Cuicui Lyu, Wenyi Lu, et al.. (2020). Acute Graft-Versus-Host Disease After Humanized Anti-CD19-CAR T Therapy in Relapsed B-ALL Patients After Allogeneic Hematopoietic Stem Cell Transplant. Frontiers in Oncology. 10. 573822–573822. 39 indexed citations
14.
Ju, Wen, Tiantian Sun, Wenyi Lu, et al.. (2020). Reference gene selection and validation for mRNA expression analysis by RT-qPCR in murine M1- and M2-polarized macrophage. Molecular Biology Reports. 47(4). 2735–2748. 10 indexed citations
15.
Lu, Wenyi, Rui Sun, Xin Jin, et al.. (2019). Anti-CD19 Chimeric Antigen Receptor T Cells in Combination With Nivolumab Are Safe and Effective Against Relapsed/Refractory B-Cell Non-hodgkin Lymphoma. Frontiers in Oncology. 9. 767–767. 114 indexed citations
16.
Zeng, Jing, Xi Zhang, Chao Sun, et al.. (2019). Feasibility study and reference values of FibroScan 502 with M probe in healthy preschool children aged 5 years. BMC Pediatrics. 19(1). 129–129. 21 indexed citations
17.
Lu, Wenyi, Xi Zhang, Jiang Wu, et al.. (2019). Association between trimester-specific gestational weight gain and childhood obesity at 5 years of age: results from Shanghai obesity cohort. BMC Pediatrics. 19(1). 139–139. 15 indexed citations
18.
Jin, Xin, Xiaoyuan He, Xiaoli Cao, et al.. (2018). Iron overload impairs normal hematopoietic stem and progenitor cells through reactive oxygen species and shortens survival in myelodysplastic syndrome mice. Haematologica. 103(10). 1627–1634. 48 indexed citations
19.
Chen, Jie, Wenyi Lu, Mingfeng Zhao, et al.. (2017). Reactive oxygen species mediated T lymphocyte abnormalities in an iron-overloaded mouse model and iron-overloaded patients with myelodysplastic syndromes. Annals of Hematology. 96(7). 1085–1095. 31 indexed citations
20.
Zhao, Mingfeng, Nan Zhao, Wenyi Lu, et al.. (2013). Multiple Cytotoxic Factors Involved in IL-21 Enhanced Antitumor Function of CIK Cells Signaled through STAT-3 and STAT5b Pathways. Asian Pacific Journal of Cancer Prevention. 14(10). 5825–5831. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seongseok Yun Breakdown of academic impact, for papers by Patrick J. Kerzic Breakdown of academic impact, for papers by Imran Ahmad Breakdown of academic impact, for papers by Hisakazu Nishimori Breakdown of academic impact, for papers by Keisuke Maeshima Breakdown of academic impact, for papers by Sergiu Paşca Breakdown of academic impact, for papers by Klara Dalva Breakdown of academic impact, for papers by Alexander Gural Breakdown of academic impact, for papers by Е. Н. Паровичникова Breakdown of academic impact, for papers by Michaela Schwarz
Rankless by CCL
2026